Findling RL - Search Results

1

Risperidone in the treatment of children and adolescents with schizophrenia: a retrospective study.

Grcevich SJ, Findling RL, Rowane WA, Friedman L, Schulz SC. Grcevich SJ, et al. Among authors: findling rl. J Child Adolesc Psychopharmacol. 1996 Winter;6(4):251-7. doi: 10.1089/cap.1996.6.251. J Child Adolesc Psychopharmacol. 1996. PMID: 9231318

2

Adolescent schizophrenia: a methodologic review of the current neuroimaging and neuropsychologic literature.

Findling RL, Friedman L, Kenny JT, Swales TP, Cola DM, Schulz SC. Findling RL, et al. J Autism Dev Disord. 1995 Dec;25(6):627-39. doi: 10.1007/BF02178192. J Autism Dev Disord. 1995. PMID: 8720031 Review.

3

Antipsychotic medications in children and adolescents.

Findling RL, Grcevich SJ, Lopez I, Schulz SC. Findling RL, et al. J Clin Psychiatry. 1996;57 Suppl 9:19-23. J Clin Psychiatry. 1996. PMID: 8823346 Review.

4

Pre-morbid asociality in neuroleptic-resistant and neuroleptic-responsive schizophrenia.

Findling RL, Jayathilake K, Meltzer HY. Findling RL, et al. Psychol Med. 1996 Sep;26(5):1033-41. doi: 10.1017/s0033291700035352. Psychol Med. 1996. PMID: 8878335

5

Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance.

Meltzer HY, Rabinowitz J, Lee MA, Cola PA, Ranjan R, Findling RL, Thompson PA. Meltzer HY, et al. Among authors: findling rl. Am J Psychiatry. 1997 Apr;154(4):475-82. doi: 10.1176/ajp.154.4.475. Am J Psychiatry. 1997. PMID: 9090333

6

An open clinical trial of risperidone monotherapy in young children with autistic disorder.

Findling RL, Maxwell K, Wiznitzer M. Findling RL, et al. Psychopharmacol Bull. 1997;33(1):155-9. Psychopharmacol Bull. 1997. PMID: 9133768 Clinical Trial.

7

Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.

Findling RL. Findling RL. J Child Adolesc Psychopharmacol. 1996 Fall;6(3):165-75. doi: 10.1089/cap.1996.6.165. J Child Adolesc Psychopharmacol. 1996. PMID: 9231310

8

High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutary effects in a double-blind, placebo-controlled study.

Findling RL, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Wiznitzer M. Findling RL, et al. J Autism Dev Disord. 1997 Aug;27(4):467-78. doi: 10.1023/a:1025861522935. J Autism Dev Disord. 1997. PMID: 9261669 Clinical Trial.

9

Cognitive impairment in adolescents with schizophrenia.

Kenny JT, Friedman L, Findling RL, Swales TP, Strauss ME, Jesberger JA, Schulz SC. Kenny JT, et al. Among authors: findling rl. Am J Psychiatry. 1997 Nov;154(11):1613-5. doi: 10.1176/ajp.154.11.1613. Am J Psychiatry. 1997. PMID: 9356577

10

Treatment and outcomes in adolescents with schizophrenia.

Schulz SC, Findling RL, Friedman L, Kenny JT, Wise AL. Schulz SC, et al. Among authors: findling rl. J Clin Psychiatry. 1998;59 Suppl 1:50-4; discussion 55-6. J Clin Psychiatry. 1998. PMID: 9448669 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

495 results

Search Page

Filters